The efiicacy and safety of Rikkunshito for nausea and appetite loss in the treatment for HCC by TAI

The efiicacy and safety of Rikkunshito for nausea and appetite loss in the treatment for HCC by TAI - The efiicacy and safety of Rikkunshito for nausea and appetite loss in the treatment for HCC by TAI

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009829

Enrollment

Registered

2013-01-21

Start date

2008-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HCC

Interventions

Rikkunshito No treatment

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: HCC who are treated by TAI

Exclusion criteria

Exclusion criteria: It depends on Physician's dicision

Design outcomes

Primary

Measure	Time frame
Improvement of nausea and appetite loss	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026